Showing results (171-180 of 229) with videos related to

Sort By:
Pageof 23
Chronobiology International|August 21, 2020
DRD2 C957T genotype modulates the time-on-task effect during total sleep deprivationRachael A Muck, Hans P A Van Dongen, Michelle A Schmidt, et al.
Journal of Sleep Research|October 7, 2022
Effects of total sleep deprivation on components of top-down attentional control using a flexible attentional control taskAnthony R Stenson, Paul Whitney, John M Hinson, et al.
British Journal of Clinical Pharmacology|October 30, 2019
Population pharmacokinetics of vancomycin in obesity: Finding the optimal dose for (morbidly) obese individualsCornelis Smit, Roeland E Wasmann, Sebastiaan C Goulooze, et al.
Nature and Science of Sleep|June 1, 2022
Simulated Night-Shift Schedule Disrupts the Plasma Lipidome and Reveals Early Markers of Cardiovascular Disease RiskJennifer E Kyle, Lisa M Bramer, Daniel Claborne, et al.
BMC Anesthesiology|July 1, 2022
Preoperative frailty and chronic pain after cardiac surgery: a prospective observational studyBritta C Arends, Leon Timmerman, Lisette M Vernooij, et al.
The British Journal of Psychiatry : the Journal of Mental Science|October 1, 1993
Ritanserin, a selective 5-HT2/1C antagonist, and negative symptoms in schizophrenia. A placebo-controlled double-blind trialS J Duinkerke, P A Botter, A A Jansen, et al.
Clinical Pharmacokinetics|May 17, 2017
Influence of Morbid Obesity on the Pharmacokinetics of Morphine, Morphine-3-Glucuronide, and Morphine-6-GlucuronideSjoerd de Hoogd, Pyry A J Välitalo, Albert Dahan, et al.
Pageof 23